Novosanis Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 20

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Novosanis General Information

Description

Developer of medical devices designed to improve the quality of diagnostics tests as well as the accuracy of drug delivery. The company's devices range from injection appliances to in vitro diagnostic accessories that are suited for the collection of first void urine which provides an improved diagnosis of sexually transmitted infections and cancer, thereby helping physicians to treat the patients.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Bijkhoevelaan 32c
  • 2110 Wijnegem
  • Belgium
+32 03
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Parent Company
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Bijkhoevelaan 32c
  • 2110 Wijnegem
  • Belgium
+32 03

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novosanis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 04-Jan-2019 Completed Generating Revenue
7. Angel (individual) 10-Jul-2018 Completed Generating Revenue
6. Grant 04-Apr-2017 Completed Generating Revenue
5. Angel (individual) 26-Jan-2017 Completed Generating Revenue
4. Grant 15-Sep-2015 Completed Generating Revenue
3. Grant 13-Aug-2014 Completed Generating Revenue
2. Seed Round 19-Jul-2013 $636K $636K Completed Generating Revenue
1. University Spin-Out 12-Mar-2013 Completed Startup
To view Novosanis’s complete valuation and funding history, request access »

Novosanis Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class B
Class A
Class B
Class A
Class B
Class A
Class B
Class A
Class B 18,000 $24.97 $24.97 1x $24.97 8.82%
Class B 20,000 $28.43 $28.43 1x $28.43 9.8%
To view Novosanis’s complete cap table history, request access »

Novosanis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medical devices designed to improve the quality of diagnostics tests as well as the accuracy of drug delive
Medical Supplies
Wijnegem, Belgium
20 As of 2023

Puteaux, France
 

Saint Louis, MO
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Novosanis Competitors (10)

One of Novosanis’s 10 competitors is ELITechGroup, a Formerly PE-Backed company based in Puteaux, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ELITechGroup Formerly PE-Backed Puteaux, France
BacterioScan Formerly VC-backed Saint Louis, MO
LEX Diagnostics Corporation Melbourn, United Kingdom
Advanced Molecular Diagnostics Corporation Nottingham, United Kingdom
Lightpoint Medical Formerly VC-backed Amersham, United Kingdom
You’re viewing 5 of 10 competitors. Get the full list »

Novosanis Patents

Novosanis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-217484-S Floater for a liquid collection device Active 25-May-2022
EP-4045114-A1 Needle adaptor and assembly for forming an injection device for administering a fluid to a subject Pending 16-Oct-2019
JP-2022552866-A Needle adapter and assembly for forming an injection device for administering fluid to a subject Pending 16-Oct-2019
CA-3158194-A1 Needle adaptor and assembly for forming an injection device for administering a fluid to a subject Pending 16-Oct-2019
EP-4041091-A2 Small volume liquid sampler Active 07-Oct-2019 A61B10/007
To view Novosanis’s complete patent history, request access »

Novosanis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novosanis Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Horizon 2020 SME Instrument Government Minority
Taste Westerlund Family Office Minority
To view Novosanis’s complete investors history, request access »

Novosanis FAQs

  • When was Novosanis founded?

    Novosanis was founded in 2013.

  • Where is Novosanis headquartered?

    Novosanis is headquartered in Wijnegem, Belgium.

  • What is the size of Novosanis?

    Novosanis has 20 total employees.

  • What industry is Novosanis in?

    Novosanis’s primary industry is Medical Supplies.

  • Is Novosanis a private or public company?

    Novosanis is a Private company.

  • What is Novosanis’s current revenue?

    The current revenue for Novosanis is .

  • How much funding has Novosanis raised over time?

    Novosanis has raised $2.12M.

  • Who are Novosanis’s investors?

    Horizon 2020 SME Instrument and Taste Westerlund have invested in Novosanis.

  • Who are Novosanis’s competitors?

    ELITechGroup, BacterioScan, LEX Diagnostics, Advanced Molecular Diagnostics, and Lightpoint Medical are some of the 10 competitors of Novosanis.

  • When was Novosanis acquired?

    Novosanis was acquired on 04-Jan-2019.

  • Who acquired Novosanis?

    Novosanis was acquired by Orasure Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »